Metraipolis › archive › dc_eeced96eb2a4

Early Dapagliflozin and Melatonin Treatment Ameliorated LV Fibrosis via Suppressing TGF-β1/Smads and Activating Nrf2-ARE Signaling in MI Rodent — Europe PMC PMID:41925092

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41925092
DOI
10.1002/kjm2.70205
License (as archived)
solo-consultazione
Archived
2026-11-03T10:40:04.570Z
SHA-256 of the archived text
c678267ff63c19baf1b42413aaa338aae370e90d7245261d9a4ccfdbe6fa9ec3
Stable URL of this page
https://metraipolis.com/documento/dc_eeced96eb2a4

How to cite

Early Dapagliflozin and Melatonin Treatment Ameliorated LV Fibrosis via Suppressing TGF-β1/Smads and Activating Nrf2-ARE Signaling in MI Rodent — Europe PMC PMID:41925092 — Europe PMC (en), https://europepmc.org/article/MED/41925092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eeced96eb2a4 (Metraipolis archive dc_eeced96eb2a4, sha256 c678267ff63c19baf1b42413aaa338aae370e90d7245261d9a4ccfdbe6fa9ec3)
BibTeX
@misc{dceeced96eb2a4,
  title = {Early Dapagliflozin and Melatonin Treatment Ameliorated LV Fibrosis via Suppressing TGF-β1/Smads and Activating Nrf2-ARE Signaling in MI Rodent — Europe PMC PMID:41925092},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41925092},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eeced96eb2a4; sha256 c678267ff63c19baf1b42413aaa338aae370e90d7245261d9a4ccfdbe6fa9ec3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41925092. Agents can read the archived copy with the MCP tool read_document.